nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ABCA5—parotid gland—salivary gland cancer	0.0273	0.11	CbGeAlD
Tacrolimus—ABCA5—saliva-secreting gland—salivary gland cancer	0.0262	0.105	CbGeAlD
Tacrolimus—PPP3CA—parotid gland—salivary gland cancer	0.0185	0.0743	CbGeAlD
Tacrolimus—PPP3CA—saliva-secreting gland—salivary gland cancer	0.0177	0.0712	CbGeAlD
Tacrolimus—MTOR—neck—salivary gland cancer	0.0168	0.0674	CbGeAlD
Tacrolimus—PPP3CA—connective tissue—salivary gland cancer	0.0163	0.0654	CbGeAlD
Tacrolimus—FKBP1A—neck—salivary gland cancer	0.0151	0.0606	CbGeAlD
Tacrolimus—MTOR—connective tissue—salivary gland cancer	0.012	0.0483	CbGeAlD
Tacrolimus—PPP3CA—lymphoid tissue—salivary gland cancer	0.0119	0.0478	CbGeAlD
Tacrolimus—MTOR—epithelium—salivary gland cancer	0.0114	0.0459	CbGeAlD
Tacrolimus—FKBP1A—connective tissue—salivary gland cancer	0.0108	0.0434	CbGeAlD
Tacrolimus—FKBP1A—epithelium—salivary gland cancer	0.0103	0.0412	CbGeAlD
Tacrolimus—ABCA5—lymph node—salivary gland cancer	0.00993	0.0399	CbGeAlD
Tacrolimus—MTOR—lymphoid tissue—salivary gland cancer	0.00878	0.0353	CbGeAlD
Tacrolimus—FKBP1A—lymphoid tissue—salivary gland cancer	0.0079	0.0318	CbGeAlD
Tacrolimus—PPP3CA—lymph node—salivary gland cancer	0.00671	0.027	CbGeAlD
Tacrolimus—MTOR—lymph node—salivary gland cancer	0.00495	0.0199	CbGeAlD
Tacrolimus—FKBP1A—lymph node—salivary gland cancer	0.00446	0.0179	CbGeAlD
Tacrolimus—ORM1—lymph node—salivary gland cancer	0.00349	0.014	CbGeAlD
Tacrolimus—ALB—lymph node—salivary gland cancer	0.00306	0.0123	CbGeAlD
Tacrolimus—ABCB1—epithelium—salivary gland cancer	0.00237	0.00954	CbGeAlD
Tacrolimus—ABCB1—lymphoid tissue—salivary gland cancer	0.00183	0.00735	CbGeAlD
Tacrolimus—ABCB1—lymph node—salivary gland cancer	0.00103	0.00415	CbGeAlD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—salivary gland cancer	0.000472	0.000628	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000468	0.000623	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—WNT5B—salivary gland cancer	0.000468	0.000623	CbGpPWpGaD
Tacrolimus—MTOR—Disease—DTX4—salivary gland cancer	0.00046	0.000612	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MARCKS—salivary gland cancer	0.000459	0.000611	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—JAG1—salivary gland cancer	0.000453	0.000603	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL17RD—salivary gland cancer	0.000452	0.000602	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FGFR4—salivary gland cancer	0.000451	0.000601	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CYLD—salivary gland cancer	0.000451	0.0006	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—PTEN—salivary gland cancer	0.000447	0.000595	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—HRAS—salivary gland cancer	0.000446	0.000593	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FBXW7—salivary gland cancer	0.000444	0.000591	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—HRAS—salivary gland cancer	0.000442	0.000589	CbGpPWpGaD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000437	0.000582	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—MAP2K2—salivary gland cancer	0.000437	0.000581	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—FOXO3—salivary gland cancer	0.000434	0.000577	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PRKDC—salivary gland cancer	0.000432	0.000575	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—PTEN—salivary gland cancer	0.000431	0.000573	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.000428	0.00057	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PYGB—salivary gland cancer	0.000427	0.000568	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—FOXO3—salivary gland cancer	0.000416	0.000554	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—FOXO3—salivary gland cancer	0.000415	0.000552	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAML3—salivary gland cancer	0.000413	0.00055	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FGF16—salivary gland cancer	0.000412	0.000548	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAML2—salivary gland cancer	0.000411	0.000548	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—EP300—salivary gland cancer	0.000411	0.000547	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000409	0.000544	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ISYNA1—salivary gland cancer	0.000407	0.000542	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000404	0.000538	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NUP62—salivary gland cancer	0.000395	0.000526	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000391	0.000521	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MYB—salivary gland cancer	0.00039	0.000519	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000385	0.000513	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FGF16—salivary gland cancer	0.00038	0.000506	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000379	0.000504	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000375	0.000499	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—FOXO3—salivary gland cancer	0.000374	0.000498	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—HRAS—salivary gland cancer	0.000372	0.000495	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—PIK3CA—salivary gland cancer	0.00037	0.000492	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MC3R—salivary gland cancer	0.000369	0.00049	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000368	0.00049	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000366	0.000487	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NUP62—salivary gland cancer	0.000365	0.000485	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000364	0.000485	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—PIK3CA—salivary gland cancer	0.000363	0.000482	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000362	0.000482	CbGpPWpGaD
Tacrolimus—MTOR—Disease—VCAN—salivary gland cancer	0.000362	0.000482	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOTCH1—salivary gland cancer	0.000358	0.000476	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000357	0.000476	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—salivary gland cancer	0.000357	0.000475	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—HRAS—salivary gland cancer	0.000356	0.000474	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000355	0.000472	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000354	0.000471	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MAP2K2—salivary gland cancer	0.000354	0.000471	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—JAG1—salivary gland cancer	0.000351	0.000468	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CREBBP—salivary gland cancer	0.000351	0.000468	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ISYNA1—salivary gland cancer	0.000351	0.000466	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FGFR4—salivary gland cancer	0.00035	0.000466	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CDH1—salivary gland cancer	0.000349	0.000464	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PHGDH—salivary gland cancer	0.000348	0.000463	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FBXW7—salivary gland cancer	0.000344	0.000458	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—HRAS—salivary gland cancer	0.000342	0.000455	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000341	0.000454	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000341	0.000454	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—PIK3CA—salivary gland cancer	0.000341	0.000454	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—HRAS—salivary gland cancer	0.00034	0.000453	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	0.000339	0.000451	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—HRAS—salivary gland cancer	0.000339	0.000451	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MAP2K2—salivary gland cancer	0.000339	0.000451	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000338	0.00045	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—HRAS—salivary gland cancer	0.000337	0.000449	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—HRAS—salivary gland cancer	0.000335	0.000446	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000335	0.000446	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—EP300—salivary gland cancer	0.000335	0.000446	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ST3GAL4—salivary gland cancer	0.000335	0.000446	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000334	0.000444	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MARCKS—salivary gland cancer	0.000332	0.000442	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000331	0.00044	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MAML2—salivary gland cancer	0.00033	0.00044	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—PTEN—salivary gland cancer	0.000329	0.000438	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CREBBP—salivary gland cancer	0.000324	0.000432	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DTX4—salivary gland cancer	0.000322	0.000429	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00032	0.000426	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—PIK3CA—salivary gland cancer	0.000316	0.00042	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—HRAS—salivary gland cancer	0.000316	0.00042	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000316	0.00042	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000316	0.00042	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000316	0.00042	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—HRAS—salivary gland cancer	0.000313	0.000416	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.00031	0.000413	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—HRAS—salivary gland cancer	0.000309	0.000411	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PYGB—salivary gland cancer	0.000308	0.00041	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000307	0.000409	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MAP2K2—salivary gland cancer	0.000306	0.000407	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FGFR4—salivary gland cancer	0.000304	0.000405	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AQP1—salivary gland cancer	0.000304	0.000405	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—PIK3CA—salivary gland cancer	0.000304	0.000404	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000302	0.000402	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FBXW7—salivary gland cancer	0.000299	0.000398	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—HRAS—salivary gland cancer	0.000292	0.000389	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FOXO3—salivary gland cancer	0.00029	0.000386	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MARCKS—salivary gland cancer	0.000286	0.00038	CbGpPWpGaD
Tacrolimus—MTOR—Disease—JAG1—salivary gland cancer	0.000282	0.000376	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—HRAS—salivary gland cancer	0.000281	0.000374	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FGFR4—salivary gland cancer	0.000281	0.000374	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000281	0.000374	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000279	0.000372	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOTCH1—salivary gland cancer	0.000277	0.000369	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FBXW7—salivary gland cancer	0.000276	0.000368	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000274	0.000365	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGF16—salivary gland cancer	0.000266	0.000355	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PYGB—salivary gland cancer	0.000266	0.000354	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CREBBP—salivary gland cancer	0.000263	0.00035	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FOXO3—salivary gland cancer	0.000253	0.000336	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CREBBP—salivary gland cancer	0.000252	0.000335	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PHGDH—salivary gland cancer	0.000251	0.000335	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PTEN—salivary gland cancer	0.000251	0.000334	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CDH1—salivary gland cancer	0.000251	0.000334	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOTCH1—salivary gland cancer	0.000251	0.000333	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.00025	0.000333	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	0.000242	0.000322	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NUP62—salivary gland cancer	0.000241	0.000321	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—salivary gland cancer	0.00024	0.000319	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—EP300—salivary gland cancer	0.000239	0.000318	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—VCAN—salivary gland cancer	0.000239	0.000318	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000237	0.000316	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FOXO3—salivary gland cancer	0.000233	0.00031	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000233	0.00031	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—PIK3CA—salivary gland cancer	0.000232	0.000309	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTEN—salivary gland cancer	0.000232	0.000308	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAML2—salivary gland cancer	0.000231	0.000308	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CREBBP—salivary gland cancer	0.000227	0.000302	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—EP300—salivary gland cancer	0.000221	0.000294	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AQP1—salivary gland cancer	0.00022	0.000292	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PHGDH—salivary gland cancer	0.000217	0.000288	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—HRAS—salivary gland cancer	0.000215	0.000286	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ST3GAL4—salivary gland cancer	0.000208	0.000277	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAP2K2—salivary gland cancer	0.000206	0.000274	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000203	0.00027	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JAG1—salivary gland cancer	0.000198	0.000263	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGFR4—salivary gland cancer	0.000197	0.000262	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000196	0.000261	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000194	0.000259	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000194	0.000258	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FBXW7—salivary gland cancer	0.000194	0.000258	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MAP2K2—salivary gland cancer	0.00019	0.000253	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.00019	0.000253	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AQP1—salivary gland cancer	0.000189	0.000252	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000189	0.000252	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PTEN—salivary gland cancer	0.000188	0.00025	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000187	0.000249	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000183	0.000243	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PTEN—salivary gland cancer	0.00018	0.00024	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTEN—salivary gland cancer	0.00018	0.000239	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—HRAS—salivary gland cancer	0.000179	0.000239	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EP300—salivary gland cancer	0.000179	0.000238	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PIK3CA—salivary gland cancer	0.000177	0.000236	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CREBBP—salivary gland cancer	0.000176	0.000234	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000174	0.000232	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000173	0.00023	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EP300—salivary gland cancer	0.000171	0.000228	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCND1—salivary gland cancer	0.000168	0.000224	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000166	0.000221	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HRAS—salivary gland cancer	0.000164	0.000218	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PIK3CA—salivary gland cancer	0.000163	0.000217	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FOXO3—salivary gland cancer	0.000163	0.000217	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTEN—salivary gland cancer	0.000162	0.000216	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOTCH1—salivary gland cancer	0.000156	0.000208	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EP300—salivary gland cancer	0.000155	0.000206	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000154	0.000205	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CREBBP—salivary gland cancer	0.000153	0.000204	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDH1—salivary gland cancer	0.000152	0.000202	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HRAS—salivary gland cancer	0.000151	0.000201	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NUP62—salivary gland cancer	0.00015	0.0002	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—VCAN—salivary gland cancer	0.000149	0.000198	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—CREBBP—salivary gland cancer	0.000144	0.000191	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000143	0.000191	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CREBBP—salivary gland cancer	0.000141	0.000188	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.00014	0.000187	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000138	0.000184	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000134	0.000178	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000133	0.000177	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PIK3CA—salivary gland cancer	0.000133	0.000176	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000132	0.000175	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000131	0.000174	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—VCAN—salivary gland cancer	0.00013	0.000174	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCND1—salivary gland cancer	0.00013	0.000173	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000127	0.000169	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PIK3CA—salivary gland cancer	0.000127	0.000169	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTEN—salivary gland cancer	0.000126	0.000167	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000124	0.000165	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—HRAS—salivary gland cancer	0.000123	0.000163	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EP300—salivary gland cancer	0.00012	0.00016	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HRAS—salivary gland cancer	0.000118	0.000157	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HRAS—salivary gland cancer	0.000117	0.000156	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000117	0.000156	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PIK3CA—salivary gland cancer	0.000114	0.000152	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000113	0.00015	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—salivary gland cancer	0.000111	0.000147	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PTEN—salivary gland cancer	0.000109	0.000146	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000109	0.000145	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000109	0.000145	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HRAS—salivary gland cancer	0.000106	0.000141	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EP300—salivary gland cancer	0.000104	0.000139	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000102	0.000136	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTEN—salivary gland cancer	0.000101	0.000134	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CREBBP—salivary gland cancer	9.91e-05	0.000132	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—EP300—salivary gland cancer	9.78e-05	0.00013	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EP300—salivary gland cancer	9.63e-05	0.000128	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CREBBP—salivary gland cancer	9.35e-05	0.000124	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	9.33e-05	0.000124	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.9e-05	0.000118	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PIK3CA—salivary gland cancer	8.87e-05	0.000118	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—salivary gland cancer	8.58e-05	0.000114	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HRAS—salivary gland cancer	8.21e-05	0.000109	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NUP62—salivary gland cancer	8.1e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—VCAN—salivary gland cancer	8.04e-05	0.000107	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PIK3CA—salivary gland cancer	7.72e-05	0.000103	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCND1—salivary gland cancer	7.33e-05	9.75e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PIK3CA—salivary gland cancer	7.23e-05	9.63e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HRAS—salivary gland cancer	7.14e-05	9.5e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PIK3CA—salivary gland cancer	7.13e-05	9.48e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTEN—salivary gland cancer	7.07e-05	9.41e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—salivary gland cancer	7e-05	9.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CREBBP—salivary gland cancer	6.76e-05	8.99e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EP300—salivary gland cancer	6.75e-05	8.98e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HRAS—salivary gland cancer	6.69e-05	8.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTEN—salivary gland cancer	6.68e-05	8.89e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HRAS—salivary gland cancer	6.59e-05	8.77e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.58e-05	8.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—EP300—salivary gland cancer	6.37e-05	8.47e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CREBBP—salivary gland cancer	5.82e-05	7.75e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CREBBP—salivary gland cancer	5.1e-05	6.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CA—salivary gland cancer	4.99e-05	6.64e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—salivary gland cancer	4.83e-05	6.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTEN—salivary gland cancer	4.83e-05	6.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	4.71e-05	6.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HRAS—salivary gland cancer	4.62e-05	6.14e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—EP300—salivary gland cancer	4.6e-05	6.13e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTEN—salivary gland cancer	4.16e-05	5.53e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—EP300—salivary gland cancer	3.96e-05	5.28e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTEN—salivary gland cancer	3.64e-05	4.85e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—EP300—salivary gland cancer	3.47e-05	4.62e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	3.4e-05	4.53e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.14e-05	4.18e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CA—salivary gland cancer	2.93e-05	3.9e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CA—salivary gland cancer	2.57e-05	3.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.24e-05	2.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—EP300—salivary gland cancer	2.14e-05	2.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.58e-05	2.11e-05	CbGpPWpGaD
